Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia [0.03%]
用于治疗精神分裂症患者尼古丁依赖的药物研发
Ivan D Montoya,Frank Vocci
Ivan D Montoya
The development of medications for the treatment of nicotine dependence in patients with schizophrenia is a public health priority due to its high prevalence rates, devastating medical consequences, and difficulty to treat. It has been hypo...
Sherry Leonard,Sharon Mexal,Robert Freedman
Sherry Leonard
Schizophrenia is a common mental illness with a high prevalence of smoking. More than 80% of schizophrenics smoke compared to 25% of the general population. Both schizophrenia and tobacco use have strong genetic components, which may overla...
HIV-RISK BEHAVIORS AMONG PSYCHIATRICALLY HOSPITALIZED ADOLESCENTS WITH AND WITHOUT COMORBID SUD [0.03%]
伴有/不伴有精神活性物质使用障碍的住院青少年的精神疾病及HIV危险行为研究
Ana M Abrantes,David R Strong,Susan E Ramsey et al.
Ana M Abrantes et al.
OBJECTIVE: The purpose of this study was to examine HIV-risk behaviors among a sample of psychiatric inpatient adolescents with and without comorbid SUD. METHOD: 239 adolescents (60.7% female; mean age=15.3) were interviewed while hospitali...